AChE/Abeta-IN-3 (Compound AM5) is a dual inhibitor of AChE and Amyloid-beta aggregation, with IC50 values of 1.29 and 4.93 µM, respectively. This compound exhibits antioxidant properties, reducing ROS and normalizing their levels. It is applicable in the study of neurological disorders such as Alzheimers disease.
